Stay updated with breaking news from Nina mojas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Momelotinib gets market authorization from the European Commission for patients with MPNs and disease-related splenomegaly or moderate to severe anemia. ....
Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer. ....
GSK said its Omjjara medicine for the treatment of splenomegaly an enlarged spleen or symptoms in adult myelofibrosis patients with moderate to severe anemia has been authorized. ....